Media & Investor Relations:
Troy Wichterman
Chief Financial Officer
(425) 402 - 1400
twichterman@biolifesolutions.com
Broadridge Corporate Issuer Solutions, Inc.
P.O. Box 1342
Brentwood, New York 11717
USA
(877) 830 - 4936
shareholder@broadridge.com
Register here to receive email notifications with updates about our press releases, stock price, SEC filings and more.
Press Releases
These are news releases that are related to our Investor efforts. Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released using the email link below.
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
- May 16 2006Stem Cells' Ability to Grow and Transform Into New Cells/Tissues Improved 67% With BioLife Product
BioLife Solutions, Inc. (BULLETIN BOARD: BLFS) , a leading manufacturer and marketer of cryopreservation solutions for the preservation of cells and tissues at low temperatures, announced today...
- Aug 15 2005
BioLife Solutions Inc. (BULLETIN BOARD: BLFS) announced today that it was granted a U.S. patent that covers the methods and compositions for the preservation of cells, tissues or organs in the...
- May 18 2005Orders to Commence in Second Quarter
BioLife Solutions Inc. (BULLETIN BOARD: BLFS) announced today that it has entered into an exclusive manufacturing and distribution agreement with VWR International, a leader in the global research...
- Mar 04 2004
BioLife Solutions Inc. (BULLETIN BOARD: BLFS) announced today the settlement of a dispute between the Company and Irvine, CA-based Endocare, Inc. , arising out of Endocare's failure to register...
- Dec 03 2003$1.38 Million in Financing; $177,000 from NIH; $1.6 Million Awarded in Court Decision
BioLife Solutions Inc. (BULLETIN BOARD: BLFS) announced today that it has secured $1.381 million through the sale in a private placement to investors, of Units consisting of Series G Convertible...
- Mar 03 2003
BioLife Solutions, Inc. (BULLETIN BOARD: BLFS) announced today that it has signed a multi-year research and development agreement with Edison, NJ-based Tissue Transformation Technologies...
- Feb 18 2003
BioLife Solutions Inc. (BULLETIN BOARD: BLFS) announced today that it has reached a key milestone in its strategy to begin positioning the Company for future sales growth with the signing of a...
- Jan 22 2003New Preservation Solution Promises to Speed Development of Pioneering Cell and Tissue Engineering Therapies
BioLife Solutions Inc. (BULLETIN BOARD: BLFS) announced today that data from a new study demonstrates that the Company's Hypothermosol® family of preservation solutions significantly extends the...
- Nov 15 2002
BioLife Solutions, Inc. (BULLETIN BOARD: BLFS) announced today results for its third quarter and nine months ended September 30, 2002, the first full quarter of operation since the divesture of...
- Nov 07 2002
BioLife Solutions, Inc. (BULLETIN BOARD: BLFS) announced today that President and CEO John Baust, Ph.D., is scheduled to make an investor presentation at the Wall Street Analyst Forum's 46th...
- Oct 22 2002
BioLife Solutions, Inc. (BULLETIN BOARD: BLFS) announced today that President and CEO John Baust, Ph.D., is scheduled to make an investor presentation at TechVest's 4th Annual Healthcare...
- Oct 21 2002
BioLife Solutions, Inc. (BULLETIN BOARD: BLFS) announced today that it has selected Irvine, CA-based Allen & Caron Inc, a full-service investor and media relations firm, to support its investor,...
- Oct 16 2002
BioLife Solutions, Inc. (BULLETIN BOARD: BLFS) announced that the National Institutes of Health (NIH) has awarded the Company a grant of $158,000 under the NIH's Small Business Innovation Research...
- Sep 30 2002Reflects Company's Focus as Developer and Marketer of Cell Preservation Technology to Biotechnology Industry
Cryomedical Sciences, Inc. (BULLETIN BOARD: BLFS) announced that effective September 30, 2002, the Company has changed its name to BioLife Solutions, Inc. and will begin to trade under the new...
- Jun 27 2002Board Approves Name Change to BioLife Solutions, Inc., New CEO And New Strategic Focus
Cryomedical Sciences, Inc. (BULLETIN BOARD: CRYM) (CMS) announced today that it has completed the sale of its cryosurgery product line and related intellectual property assets to Irvine, CA-based...
- May 29 2002Announces New CEO, Proposed Name Change and New Strategic Focus on Proprietary Cell and Tissue Preservation Products
Cryomedical Sciences, Inc. (BULLETIN BOARD: CRYM) (CMS) announced that it has executed a definitive agreement to sell its cryosurgical product line and related intellectual property assets to...